LY3848575 is a medication being tested to see if it can help reduce pain in people who have a condition called chronic neuropathic pain associated with distal sensory polyneuropathy. This condition causes pain due to nerve damage, often in the hands and feet. The study is trying to find out if this medication can make the pain less intense compared to not taking the medication at all. The goal is to see if this medication can be a better option for managing this type of pain.

Neuropathic Pain – Neuropathic pain is a chronic pain condition that arises from damage or dysfunction in the nervous system. It is characterized by sensations such as burning, tingling, or shooting pain, often occurring without an obvious cause. The pain can be persistent or episodic and may worsen over time. It often affects areas of the body served by the damaged nerves and can lead to increased sensitivity to touch or temperature. The condition can result from various factors, including injury, infection, or diseases affecting the nervous system. As the condition progresses, it may lead to significant discomfort and impact daily activities.

Distal Sensory Polyneuropathy – Distal sensory polyneuropathy is a disorder affecting the peripheral nerves, primarily those farthest from the central nervous system, such as in the hands and feet. It is characterized by a gradual onset of numbness, tingling, or pain in these areas. Over time, the condition can lead to a loss of sensation and muscle weakness. The progression of symptoms is typically slow, and they may spread to other parts of the body. This condition can result from various causes, including diabetes, infections, or exposure to toxins. As it advances, it can significantly affect balance and coordination.